104 related articles for article (PubMed ID: 11771428)
1. [Quality control in tumor marker values: methology, results and potential problems].
Ben Ayed M; Ben Hadj Hmida Y; Kassis M; Damak J; Masmoudi H
Tunis Med; 2001; 79(6-7):341-7. PubMed ID: 11771428
[TBL] [Abstract][Full Text] [Related]
2. [Sense and nonsense of tumor markers in practice].
Joss R; Cerny T
Schweiz Med Wochenschr; 1990 May; 120(19):693-703. PubMed ID: 1693445
[TBL] [Abstract][Full Text] [Related]
3. [Cryptates applied in tumor marker assays (CEA, AFP, CA 15.3, CA19.9): evaluation of Kryptor (Cis-Bio) analyser].
Gherardi C; Roumier AS; Dubucquoi S; Dessaint JP
Ann Biol Clin (Paris); 1998; 56(1):92-5. PubMed ID: 9754229
[No Abstract] [Full Text] [Related]
4. Comparison of the test methods (KRYPTOR, ES 600 and CIS-RIA) for CEA, CA 15-3 and CA 125 follow-up and ONCOCHECK-quality control.
Bauer T; Charl S; Sturm G
Anticancer Res; 2000; 20(6D):5245-7. PubMed ID: 11326703
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of four serological tumor markers for the detection of breast cancer.
Clinton SR; Beason KL; Bryant S; Johnson JT; Jackson M; Wilson C; Holifield K; Vincent C; Hall M
Biomed Sci Instrum; 2003; 39():408-14. PubMed ID: 12724928
[TBL] [Abstract][Full Text] [Related]
6. The importance of serum and ascites fluid alpha-fetoprotein, carcinoembryonic antigen, CA 19-9, and CA 15-3 levels in differential diagnosis of ascites etiology.
Sari R; Yildirim B; Sevinc A; Bahceci F; Hilmioglu F
Hepatogastroenterology; 2001; 48(42):1616-21. PubMed ID: 11813585
[TBL] [Abstract][Full Text] [Related]
7. Combined measurement of serum sialyl Lewis X with serum CA15-3 in breast cancer patients.
Kurebayashi J; Nomura T; Hirono M; Okubo S; Udagawa K; Shiiki S; Ikeda M; Nakashima K; Tanaka K; Sonoo H
Jpn J Clin Oncol; 2006 Mar; 36(3):150-3. PubMed ID: 16520359
[TBL] [Abstract][Full Text] [Related]
8. [Tumor markers and ovarian cancer].
Trifonov I; Todorova M
Akush Ginekol (Sofiia); 2002; 41 Suppl 1():7-11. PubMed ID: 12412346
[No Abstract] [Full Text] [Related]
9. External quality control results for hormones, tumor markers and CRP testing.
Tatsumi N; Kawano K; Takubo T; Nakamura H; Tsuda I
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():105-9. PubMed ID: 10926269
[TBL] [Abstract][Full Text] [Related]
10. [National external quality assessment and comparability of assays for tumor markers measurements].
Zhang JT; Zhang CB; Ma R; Zhao HJ; Wang J; Wang ZG; Chen WX
Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(14):993-7. PubMed ID: 20646652
[TBL] [Abstract][Full Text] [Related]
11. External quality control program for inter-laboratory quality control.
Bewarder N; Müller P
Anticancer Res; 2000; 20(6D):5213-6. PubMed ID: 11326697
[TBL] [Abstract][Full Text] [Related]
12. Automated microsystem for electrochemical detection of cancer markers.
Kellner C; Botero ML; Latta D; Drese K; Fragoso A; O'Sullivan CK
Electrophoresis; 2011 Apr; 32(8):926-30. PubMed ID: 21394733
[TBL] [Abstract][Full Text] [Related]
13. The impact of local guidelines on the tumour marker requesting patterns of a General Surgery Department.
Schulenburg-Brand D; Kumar N; Zouwail S
Ann Clin Biochem; 2013 Sep; 50(Pt 5):438-42. PubMed ID: 23828945
[TBL] [Abstract][Full Text] [Related]
14. Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa-foeto-protein (AFP), neuron-specific enolase (NSE) and CA19.9 from the NORIP study.
Bjerner J; Høgetveit A; Wold Akselberg K; Vangsnes K; Paus E; Bjøro T; Børmer OP; Nustad K
Scand J Clin Lab Invest; 2008; 68(8):703-13. PubMed ID: 18609108
[TBL] [Abstract][Full Text] [Related]
15. Influence of cardiopulmonary resuscitation on levels of tumour markers.
Berent R; Auer J; Porodko M; Lamm G; Weber T; Wimmer E; Seier J; Aspöck G; Eber B
Eur J Cancer Care (Engl); 2006 Jul; 15(3):252-6. PubMed ID: 16882121
[TBL] [Abstract][Full Text] [Related]
16. [Gallbladder carcinoma producing CEA, AFP, CA19-9, sialyl SSEA and CSF].
Tanigawa N
Ryoikibetsu Shokogun Shirizu; 1996; (9):237-9. PubMed ID: 8705462
[No Abstract] [Full Text] [Related]
17. [Molecular microheterogeneity of tumor marker substances and its significance of biological recognition].
Kuwabara M; Iwakoshi N; Ariyoshi Y
Nihon Rinsho; 1996 Jun; 54(6):1580-6. PubMed ID: 8691612
[TBL] [Abstract][Full Text] [Related]
18. Periodic measurement of serum carcinoembryonic antigen and carbohydrate antigen 15-3 levels as postoperative surveillance after breast cancer surgery.
Nakamura T; Kimura T; Umehara Y; Suzuki K; Okamoto K; Okumura T; Morizumi S; Kawabata T
Surg Today; 2005; 35(1):19-21. PubMed ID: 15622458
[TBL] [Abstract][Full Text] [Related]
19. [Usefulness of CEA, CA 15-3 and CA 125 tumor markers in the differential diagnostics of peritoneal effusion].
Kiluk MS; Rółkowski R; Zawadzki RJ; Wojtukiewicz MZ
Pol Merkur Lekarski; 2002 Oct; 13(76):298-301. PubMed ID: 12557435
[TBL] [Abstract][Full Text] [Related]
20. Best practice in primary care pathology: review 13.
Cabrera-Abreu JC; Smellie WS; Bowley R; Shaw N
J Clin Pathol; 2012 Feb; 65(2):97-100. PubMed ID: 22039279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
